Indication
Menorrhagia
Menorrhagia is a gynecological condition characterized by abnormally heavy or prolonged menstrual bleeding occurring at regular intervals in reproductive-aged females. Read more about Menorrhagia
23 drugs 19 manufacturers
Drugs that treat it
Common Menorrhagia therapies.
TRANEXAMIC ACID
TRANEXAMIC ACID
TRANEXAMIC ACID
TRANEXAMIC ACID
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMenorrhagia is a gynecological condition characterized by abnormally heavy or prolonged menstrual bleeding occurring at regular intervals in reproductive-aged females.
Clinically defined by menstrual blood loss exceeding 80 mL per cycle or menses extending beyond seven days, it frequently presents with the passage of large clots, rapid saturation of sanitary products, and severe disruption to daily activities.
Pathophysiologically, it may stem from structural uterine abnormalities such as leiomyomas, adenomyosis, or polyps, as well as non-structural causes including ovulatory dysfunction, localized endometrial hemostatic derangements, and systemic coagulopathies, often resulting in secondary iron deficiency anemia.
- cdc.gov
Menorrhagia is a gynecological condition characterized by abnormally heavy or prolonged menstrual bleeding occurring at regular intervals in reproductive-aged females Clinically defined by menstrual blood loss exceeding 80 mL per cycle or menses extending beyond seven days, it frequently presents with the passage of large clots, rapid saturation of sanitary products, and severe disruption to daily activities Pathophysiologically, it may stem from structural uterine abnormalities such as leiomyom...
- nih.gov
Menorrhagia is a gynecological condition characterized by abnormally heavy or prolonged menstrual bleeding occurring at regular intervals in reproductive-aged females
- nih.gov
Clinically defined by menstrual blood loss exceeding 80 mL per cycle or menses extending beyond seven days, it frequently presents with the passage of large clots, rapid saturation of sanitary products, and severe disruption to daily activities
- nih.gov
Clinically defined by menstrual blood loss exceeding 80 mL per cycle or menses extending beyond seven days, it frequently presents with the passage of large clots, rapid saturation of sanitary products, and severe disruption to daily activities Pathophysiologically, it may stem from structural uterine abnormalities such as leiomyomas, adenomyosis, or polyps, as well as non-structural causes including ovulatory dysfunction, localized endometrial hemostatic derangements, and systemic coagulopathie...
- nih.gov
Pathophysiologically, it may stem from structural uterine abnormalities such as leiomyomas, adenomyosis, or polyps, as well as non-structural causes including ovulatory dysfunction, localized endometrial hemostatic derangements, and systemic coagulopathies, often resulting in secondary iron deficiency anemia
Personalize your experience
Follow Menorrhagia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.